|
|
新型血栓与止血分子标志物在急性冠脉综合征中的研究进展
|
Abstract:
| [1] | Hansson, G.K. (2005) Inflammation, Atherosclerosis, and Coronary Artery Disease. New England Journal of Medicine, 352, 1685-1695. https://doi.org/10.1056/NEJMra043430 |
| [2] | 王琳. 血清H-FABP水平变化对急性心肌梗死早期诊断作用的初步分析[J]. 微循环学杂志, 2014, 24(2): 66-67. |
| [3] | 董炤, 刘秀珍, 刘从彬, 等. 血栓调节蛋白的临床研究进展[J]. 安徽医药, 2010, 14(4): 383-384. |
| [4] | Mosnier, L.O., Meijers, J.C. and Bouma, B.N. (2001) Regulation of Fibrinolysis in Plasma by TAFI and Protein C Is Dependent on the Concentration of Thrombomodulin. Thrombosis and Haemostasis, 85, 5-11.
https://doi.org/10.1055/s-0037-1612655 |
| [5] | Wu, Y.Z., Chang, L.H., Ren, H., et al. (2010) Changes of Thrombomodulin and Thrombomodulin Ala455Val Polymorphism(C14181) in Chinese Han Patients with Acute Cerebrovascular Diseases. International Journal of Cerebrovascular Disease, 18, 21-25. |
| [6] | Tran, N.D., Wang, L., et al. (1998) Measurement of Thrombomodulin m RNA Expression in Brain Capillaries by Polymerase Chain Reaction. Thrombosis Research, 91, 191-197. https://doi.org/10.1016/S0049-3848(98)00085-1 |
| [7] | Krumholz, H.M. (1997) Platelet Receptor Inhibition for Ischemic Syndromes. Journal Watch Cardiology, 338, 1498-1505. |
| [8] | 黄丽红, 郭民, 侯纯荣, 孟眷. 急性冠脉综合征患者血栓调节蛋白水平及临床意义[J]. 中国医药导报, 2009, 6(28): 25-26. |
| [9] | Uno, M., Tsuji, H., Watanabe, M., et al. (1989) Application of Thrombin Antithrombin & Complex for Detecting a Latent Hypercoagulable State in Patients with Coronary Heart Disease. Japanese Circulation Journal, 53, 1185-1195.
https://doi.org/10.1253/jcj.53.1185 |
| [10] | 潘志红, 张江蓉, 袁惠敏, 等. 老年人血栓调节蛋白与冠状动脉病变的相关性研究[J]. 中国综合临床, 2007(12): 1059-1060. |
| [11] | 吴方, 王学锋. 高凝状态患者止凝血分子标志物的检测及其临床意义[J]. 上海医学检验杂志, 2000, 15(3): 180-182. |
| [12] | 沈培辰, 张代富, 王娟, 马兰. 急性心肌梗死患者血浆TAT变化的价值[J]. 实用全科医学, 2005, 3(6): 477-478. |
| [13] | Giannitsis, E., Siemens, H.J., Mitusch, R., et al. (1999) Prothrombin Fragments F1+2, Thrombin Antithrombin & Complex, Fibrin Monomers and Fibrinogen in Patients with Coronary Atherosclerosis. International Journal of Cardiology, 68, 269-274. https://doi.org/10.1016/S0167-5273(98)00256-3 |
| [14] | 吕永楠, 任玮, 陈晶晶, 李晓艳. 急性心肌梗死患者血栓标志物水平变化及意义[J]. 微循环学杂志, 2017, 27(3): 43-46. |
| [15] | Kooistra, T., Schrauwen, Y., Arts, J., et al. (1994) Regulation of Endothelial Cell t-PA Synthesis and Release. International Journal of Hematology, 59, 233-255. |
| [16] | Chandler, W.L., Trimble, S.L., Loo, S.C., et al. (1990) Effect of PAI-1 Levels on the Molar Concentrations of Active Tissue Plasminogen Activator (t-PA) and t-PA/PAI-1 Complex in Plasma. Blood, 76, 930-937.
https://doi.org/10.1182/blood.V76.5.930.930 |
| [17] | Pia, L., Niklas, B., Emma, L., Erik, U., Mia, M., Karin, W., Lena, K. and Sverker, J. (2013) Histone Deacetylase Inhibitors Stimulate Tissue-Type Plasminogen Activator Production in Vascular Endothelial Cells. Journal of Thrombosis and Thrombolysis, 35, 185-192. https://doi.org/10.1007/s11239-012-0831-6 |
| [18] | Fox, K.A., Robison, A.K., Knabb, R.M., Rosamond, T.L., Sobel, B.E., et al. (1985) Prevention of Coronary Thrombosis with Subthrombolytic Doses of Tissue-Type Plasminogen Activator. Circulation, 72, 1346-1354.
https://doi.org/10.1161/01.CIR.72.6.1346 |
| [19] | Giles, A.R., Nesheim, M.E., Herring, S.W., Hoogendoorn, H., Stump, D.C., et al. (1990) The Fibrinolytic Potential of the Normal Primate Following the Generation of Thrombin in Vivo. Thrombosis and Haemostasis, 63, 476-481.
https://doi.org/10.1055/s-0038-1645069 |
| [20] | Oliver, J.J., Webb, D.J. and Newby, D.E. (2006) Stimulated Tissue Plasminogen Activator Release as a Marker of Endothelial Function in Humans. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 2470-2479.
https://doi.org/10.1161/01.ATV.0000189309.05924.88 |
| [21] | Hrafnkelsdottir, T., Gudnason, T., Wall, U., et al. (2004) Regulation of Local Availability of Active Tissue-Type Plasminogen Activator in Vivo in Man. Journal of Thrombosis and Haemostasis, 2, 1960-1968.
https://doi.org/10.1111/j.1538-7836.2004.00948.x |
| [22] | Salame, M.Y., Samani, N.J., Masood, I., et al. (2000) Expression of the Plasminogen Activator System in the Human Vascular Wall. Atherosclerosis, 152, 19-28. https://doi.org/10.1016/S0021-9150(99)00441-4 |
| [23] | Shantsila, E., Montoro-García, S., Tapp, L.D., et al. (2012) Fibrinolytic Status in Acute Coronary Syndromes: Evidence of Differences in Relation to Clinical Features and Pathophysiological Pathways. Thrombosis and Haemostasis, 108, 32-40. https://doi.org/10.1160/TH12-01-0011 |
| [24] | Lijnen, H.R. and Collen, D. (1996) Impaired Fibrinolysis and the Risk for Coronary Heart Disease. Circulation, 94, 2052-2054. https://doi.org/10.1161/01.CIR.94.9.2052 |
| [25] | Robinson, S.D., Ludlam, C.A., Boon, N.A., et al. (2007) Endothelial Fibrinolytic Capacity Predicts Future Adverse Cardiovascular Events in Patients with Coronary Heart Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, 1651-1656. https://doi.org/10.1161/ATVBAHA.107.143248 |
| [26] | Galvani, M., Ferrini, D., Ottani, F., et al. (1999) Early Risk Stratification of Unstable Angina/non-Q Myocardial Infarction: Biochemical Markers of Coronary Thrombosis. International Journal of Cardiology, 68, S55-S61.
https://doi.org/10.1016/S0167-5273(98)00292-7 |
| [27] | 胡盛寿, 高润霖, 刘力生, 等. 《中国心血管病报告2018》概要[J]. 中国循环杂志, 2019, 34(3): 209-220. |
| [28] | 高润霖, 张澍, 王增武, 等. 新中国成立七十年来我国心血管病学的发展[J]. 中国循环杂志, 2019, 34(9): 833-843. |
| [29] | Negreva, M., Georgiev, S., Prodanova, K., et al. (2016) Early Changes in the Antithrombin and Thrombin-Antithrombin Complex in the Patients with Paroxysmal Atrial Fibrillation. Cardiology Research, 7, 89-94.
https://doi.org/10.14740/cr469w |
